About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


H. Rept. 116-549 1 (2020-09-29)

handle is hein.congrecreports/crptxadjq0001 and id is 1 raw text is: AUTHENTICATEO U.S. OVERNMENT INFORMATION Op 116TH CONGRESS REPORT 2d Session HOUSE OF REPRESENTATIVES 116-549 TIMELY REAUTHORIZATION OF NECESSARY STEM-CELL PROGRAMS LENDS ACCESS TO NEEDED THERAPIES ACT OF 2019 SEPTEMBER 29, 2020.-Committed to the Committee of the Whole House on the State of the Union and ordered to be printed Mr. PALLONE, from the Committee on Energy and Commerce, submitted the following REPORT [To accompany H.R. 4764] The Committee on Energy and Commerce, to whom was referred the bill (H.R. 4764) to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes, having considered the same, reports favorably thereon without amendment and rec- ommends that the bill do pass. CONTENTS Page I. Purpose and Sum m ary .................................................................................. 1 II. Background and Need for the Legislation ................................................... 2 III. Com m ittee H earings ...................................................................................... 2 IV . Com m ittee Consideration .............................................................................. 3 V . C om m ittee V otes ............................................................................................ 3 V I. O versight Findings ........................................................................................ 3 VII. New Budget Authority, Entitlement Authority, and Tax Expenditures 4 VIII. Federal M andates Statem ent ....................................................................... 4 IX. Statement of General Performance Goals and Objectives ......................... 4 X. Duplication of Federal Program s ................................................................. 4 XI. Com m ittee Cost Estim ate ............................................................................. 4 XII. Earmarks, Limited Tax Benefits, and Limited Tariff Benefits .................. 4 XIII. Advisory Com m ittee Statem ent .................................................................... 4 XIV. Applicability to Legislative Branch ............................................................. 4 XV. Section-by-Section Analysis of the Legislation ........................................... 5 XVI. Changes in Existing Law Made by the Bill, as Reported ........................... 5 I. PURPOSE AND SUMMARY H.R. 4764, the Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2019, or the TRANSPLANT Act of 2019, introduced by Representatives Doris 99-006